Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity

OBJECTIVE: There is an unmet medical need for a safe and effective weight loss product with minimal systemic side‐effects. In this study, the effect of a novel modified‐release fixed‐dose combination of orlistat and acarbose (MR‐OA) was compared with conventional orlistat (CO) regarding tolerability...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmbäck, Ulf, Forslund, Anders, Grudén, Stefan, Alderborn, Göran, Söderhäll, Arvid, Hellström, Per M., Lennernäs, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278902/
https://www.ncbi.nlm.nih.gov/pubmed/32523721
http://dx.doi.org/10.1002/osp4.405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278902/
https://www.ncbi.nlm.nih.gov/pubmed/32523721
http://dx.doi.org/10.1002/osp4.405

Ejemplares similares